More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

(Heraldkeepers via Comtex)

To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html

 

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and cell encapsulation techniques market has been analyzed across the following segments:

  • Type of licensing deal payment
  • Upfront payment
  • Milestone payment

 

  • Therapeutic area
  • Metabolic disorder
  • Neurological disorder
  • Ophthalmic disorder
  • Oncological disorder

 

  • Target disease indication
  • Ataxia telangiectasia
  • Breast cancer
  • Diabetes
  • Glaucoma
  • Head and neck cancer
  • Macular telangectasia
  • Pancreatic cancer
  • Parkinson’s disease
  • Retinitis pigmentosa

 

  • Type of encapsulation material used
  • Alginate-based microcapsule
  • Cellulose hydrogel
  • Medical-grade plastic
  • Red blood cell

 

  • Key geographical region
  • North America
  • Europe
  • Asia-Pacific and rest of the world

 

The Cell Encapsulationv, 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • ALTuCELL
  • Azellon Cell Therapeutics
  • Beta-Cell
  • Betalin Therapeutics
  • CellProtect Biotechnology
  • Diatranz Otsuka
  • Encellin
  • EryDel
  • Gloriana Therapeutics
  • Living Cell Technologies
  • MaxiVAX
  • Neurotech Pharmaceuticals
  • PharmaCyte Biotech
  • Semma Therapeutics
  • Sernova

 

Table of Contents

 

  1. Preface
  2. Executive Summary

 

  1. Introduction

 

  1. Current Market Landscape

 

  1. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles

 

  1. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles

  1. Patent Analysis

  1. Clinical Trial Analysis

  1. Recent Partnerships

 

  1. Funding and Investment Analysis

 

  1. Grant Analysis

  1. Potential Strategic Partners

 

  1. Market Forecast

 

  1. Conclusion

 

  1. Executive Insights

 

  1. Appendix 1: Tabulated Data

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Medium – https://medium.com/@RootsAnalysis

Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/

Quora – https://rootsanalysisinsights.quora.com/

 

comtex tracking

COMTEX_409159229/2582/2022-06-24T05:40:35